Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • ERS Author FAQs
    • COVID-19 submission information
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • ERS Author FAQs
    • COVID-19 submission information
  • Alerts
  • Subscriptions

Pulmonary pharmacology and therapeutics

  • Pulmonary pharmacology and therapeutics
  • Efficacy of indacaterol/glycopyrronium versus salmeterol/fluticasone in current and ex-smokers: a pooled analysis of IGNITE trials
    David M.G. Halpin, Claus F. Vogelmeier, Karen Mezzi, Pritam Gupta, Konstantinos Kostikas, Jadwiga A. Wedzicha
    ERJ Open Research Jan 2021, 7 (1) 00816-2020; DOI: 10.1183/23120541.00816-2020
  • Characterisation of cough evoked by inhaled treprostinil and treprostinil palmitil
    Richard W. Chapman, Michel R. Corboz, Carlos Fernandez, Eugene Sullivan, Andy Stautberg, Adam J. Plaunt, Donna M. Konicek, Vladimir Malinin, Zhili Li, David Cipolla, Walter Perkins
    ERJ Open Research Jan 2021, 7 (1) 00592-2020; DOI: 10.1183/23120541.00592-2020
  • First clinical trials of the inhaled epithelial sodium channel inhibitor BI 1265162 in healthy volunteers
    Alison Mackie, Juliane Rascher, Marion Schmid, Verena Endriss, Tobias Brand, Wolfgang Seibold
    ERJ Open Research Jan 2021, 7 (1) 00447-2020; DOI: 10.1183/23120541.00447-2020
  • Lumacaftor/ivacaftor-associated health stabilisation in adults with severe cystic fibrosis
    Susannah J. King, Dominic Keating, Elyssa Williams, Eldho Paul, Brigitte M. Borg, Felicity Finlayson, Brenda M. Button, John W. Wilson, Tom Kotsimbos
    ERJ Open Research Jan 2021, 7 (1) 00203-2020; DOI: 10.1183/23120541.00203-2020
  • Indications and patterns of use of benzodiazepines and opioids in severe interstitial lung disease: a population-based longitudinal study
    Jenny Genberg, Joanna M. Davies, Zainab Ahmadi, David Currow, Miriam J. Johnson, Hanan Tanash, Sabrina Bajwah, Magnus Ekström
    ERJ Open Research Jan 2021, 7 (1) 00716-2020; DOI: 10.1183/23120541.00716-2020
  • ICS-formoterol reliever versus ICS and short-acting β2-agonist reliever in asthma: a systematic review and meta-analysis
    Lee Hatter, Pepa Bruce, Irene Braithwaite, Mark Holliday, James Fingleton, Mark Weatherall, Richard Beasley
    ERJ Open Research Jan 2021, 7 (1) 00701-2020; DOI: 10.1183/23120541.00701-2020
  • Losartan reduces cigarette smoke-induced airway inflammation and mucus hypersecretion
    Michael D. Kim, Nathalie Baumlin, John S. Dennis, Makoto Yoshida, Adrian Kis, Carolina Aguiar, Andreas Schmid, Eliana Mendes, Matthias Salathe
    ERJ Open Research Jan 2021, 7 (1) 00394-2020; DOI: 10.1183/23120541.00394-2020
  • The six million dollar man
    Mathilde Volpato, Stefan Nowak, Jean Luc Bourrain, Pascal Demoly, Engi Ahmed, Arnaud Bourdin, Jeremy Charriot
    ERJ Open Research Jan 2021, 7 (1) 00341-2020; DOI: 10.1183/23120541.00341-2020
  • Childhood-onset severe hypereosinophilic asthma: efficacy of benralizumab
    Jocelyne Just, Melisande Bourgoin, Flore Amat, Nathalie Cottel, Nathalie Lambert, Stephanie Wanin
    ERJ Open Research Oct 2020, 6 (4) 00339-2020; DOI: 10.1183/23120541.00339-2020
  • An innovative phase II trial to establish proof of efficacy and optimal dose of a new inhaled epithelial sodium channel inhibitor BI 1265162 in adults and adolescents with cystic fibrosis: BALANCE-CFTM 1
    Christopher H. Goss, Raksha Jain, Wolfgang Seibold, Anne-Caroline Picard, Ming-Chi Hsu, Abhya Gupta, Isabelle Fajac
    ERJ Open Research Oct 2020, 6 (4) 00395-2020; DOI: 10.1183/23120541.00395-2020

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Acute lung injury and critical care (23)
  • Asthma and allergy (118)
  • CF and non-CF bronchiectasis (76)
  • COPD and smoking (198)
  • Epidemiology, occupational and environmental lung disease (42)
  • Genetics (14)
  • Interstitial and orphan lung disease (99)
  • Lung biology and experimental studies (46)
  • Lung cancer (53)
  • Lung imaging (27)
  • Lung structure and function (58)
  • Mechanisms of lung disease (4)
  • Paediatric pulmonology (55)
  • Pulmonary pharmacology and therapeutics (65)
  • Pulmonary vascular disease (40)
  • Respiratory clinical practice (70)
  • Respiratory infections and tuberculosis (180)
  • Sleep medicine (39)

Custom Text goes here

  • Most Read
  • Twitter
Loading
  • Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome?
  • Pneumomediastinum and subcutaneous emphysema in COVID-19: barotrauma or lung frailty?
  • IQOS exposure impairs human airway cell homeostasis: direct comparison with traditional cigarette and e-cigarette
  • COVID-19 in children with underlying chronic respiratory diseases: survey results from 174 centres
  • There can be smoke without fire: warranted caution in promoting electronic cigarettes and heat not burn devices as a safer alternative to cigarette smoking
More...

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2021 by the European Respiratory Society